Marksans Pharma announced that CFC Finlease, a SEBI Licensed ESG Rating Provider (ERP), has voluntarily reviewed the ESG rating on the Company, based on data available in public domain for the Fiscal 2025, and assigned an ESG Score of '73'.
Powered by Capital Market - Live News